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Burn injury has been reported to be an important cause of morbidity and mortality and it is still 
considered as unmet clinical need. Although there is a myriad of effective stem cells suggested 
for skin regeneration, there is no one ideal scaffold. The aim of this study was to develop a 3D 
bi-layer scaffold made of biological decellularised human amniotic membrane (AM) with 
viscoelastic electrospun nanofibrous silk fibroin (ESF) spun on top. The fabricated 3D bi-layer 
AM/ESF scaffold was submerged in ethanol to induce β-sheet transformation as well as to get a 
tightly coated and inseparable bilayer. The biomechanical and biological properties of the 3D bi-
layer AM/ESF scaffold were investigated. The results indicate a significant improved mechanical 
properties of the AM/ESF compared to the AM alone. Both AM and AM/ESF possess a variety 
of suitable adhesion cells without detectable cytotoxicity against the Adipose Tissue-Derived 
Mesenchymal Stem Cells (AT-MSCs). The AT-MSCs show increased expression of two main 
pro-angiogenesis factors VEGFa and bFGF when cultured on the AM/ESF for 7 days in 
comparison with AM alone.  The results suggest that AM/ESF scaffold with autologous AT-
MSCs has excellent cell adhesion and proliferation along with production of growth factors 
which serves as a possible application in clinical setting in skin regeneration.  
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Full-thickness skin wounds, especially caused by 3rd degree burns with more than 10 mm in 
diameter, require skin grafting to fully heal and prevent related complications [1, 2]. Many 
attempts are made to develop an ideal skin substitute that would accelerate wound healing and 
prevent infections. An ideal skin substitute should have mechanical properties similar to normal 
skin, facilitate cell attachment, proliferation, migration and differentiation, degrade in a 
comparable rate to the formation of new skin, and prevent infections [1, 3-5] . To date, there is 
no such product; however there is a number of scaffold materials, such as decellularised bovine 
collagen based membrane (IntergraTM), silicon-based sheets and decellularised human amniotic 
membrane (AM) which can serve as next best substitutes. Unfortunately, these materials are  
quite expensive, hence skin regeneration is considered as unmet clinical need [1]. For instance, 
AM is used in the management of burn wounds today [6]. 
AM is a natural bio-scaffold and has many favourable characteristics for use as skin substitute 
including high elasticity, structural integrity, ECM composition similar to human skin, anti-
scaring effect, supportive effects on cell migration, proliferation, differentiation and antibacterial 
activity. These properties make this membrane a promising and optimal skin substitute [6-10]. It 
is reported that epithelial and mesenchymal layers of the AM have anti-angiogenic and 
angiogenic properties. Despite all the unique characteristics of AM as a wound dressing, its weak 
mechanical properties and fast degradation remain a challenge. Wet AM is hardly handled during 
the grafting and degraded before the wounds fully heal [11]. Table 1 shows the recent research 
work on skin regeneration for wound healing applications.  
Please insert Table 1 here 






































































In this work, we hypothesize to overcome the disadvantages associated with AM grafting by 
multilayer coating it with natural and optimal biomaterial such as nanofibrous silk protein. Silk 
has favourable characteristics such as aqueous preparation, superior mechanical properties, 
suitable elasticity, adequate angiogenicity and slow biodegradability. Silk fibroin of Bombyx 
mori mulberry silkworm is a cyto-biocompatible and extensively used in tissue engineering 
applications. [12-18]. A number of silk containing products are used in plastic surgery 
applications, which are approved by FDA [19].  
In this paper, we report the fabrication and characterization of bi-layer membranes made from 
decellularised human amniotic membrane (AM) and Electrospun Nanofibrous Silk Fibroin 
(ESF). Our bi-layer artificial skin substitute showed an improved angionenesis in in vitro 
evaluation by increased expression of angiogenic factors in adipose tissue-derived mesenchymal 
stem cells (AT-MSCs) when compared to AM. Our improved bi-layer artificial skin scaffold 
presents an excellent option as a skin substitute and mesenchymal stem cells carrier for skin 
tissue engineering applications.  
 
2. Materials and Methods 
2.1. Fabrication of bi-layer decellularised human amniotic membrane and electrospun 
nanofibrous silk fibroin 
2.1.1. Human amniotic membrane 
The AM samples were obtained and decellularised by a simple and cost-effective method as 
previously described [11]. Briefly, the human placentas were obtained from consenting mothers 
upon cesarean sections under sterile conditions. The samples were screened to be negative for 






































































the following agents: the human immunodeficiency virus type II, syphilis, gonorrhea, human 
hepatitis virus types B and C, toxoplasmosis and cytomegalovirus. The AM was separated from 
chorion and then treated with 0.2% EDTA and 0.5M NaOH and scraped to remove the cells. The 
sample collection and experiments were performed in accordance with the World Medical 
Association Declaration Of Helsinki [20]. The decellularisation of the membrane was confirmed 
by immunohistochemistry (IHC) and H&E staining. The decellularised membrane was dried 
under vacuum and sterilized by gamma irradiation.  
 
2.1.2. Preparation of nanofibrous silk protein fibroin by electrospinning  
2.1.2.1. Extraction and purification 
The extraction and purification of silk fibroin from cocoons of Bombyx mori mulberry silkworm 
were carried out as described previously [21]. Briefly, the cocoons were boiled at 100º C in an 
aqueous solution of 0.02 M sodium bicarbonate (Na2CO3) and the fibres were thoroughly rinsed 
with deionized water to remove the glue-like silk protein sericin. The degummed silk fibbers 
were dissolved in 9.3 M Lithium bromide (LiBr) solution at 60 ºC for 4 hours and samples were 
dialyzed  (MWCOs of 12 KDa) against ultrapure water with changes every 2 hours. The dialyzed 
fibroin solution was lyophilized and stored at room temperature until future use.  
 
2.1.2.2. Nuclear magnetic resonance (NMR) analysis 
The extracted and dried SF powder was characterized by a high resolution 13C NMR spectra (FT-
NMR (600 MHz) AVANCE 600, Bruker, Germany). The SF powder was dissolved in formic 
acid (FA) (10% w/v) and subjected to NMR analysis as described previously [22].  







































































2.1.2.3. Fourier transform infrared (FTIR) spectroscopy  
Methanol and ethanol are the most common solvents for induction of water insoluble β-sheet 
conformational transition [23-25]. The SF was treated with 70% ethanol for 1 hour. The 
molecular conformation of the SF was determined by FTIR spectroscopy (55 FTIR EQUINOX 
spectrophotometer, BrukerOptik GmbH, Germany). For this purpose, before and after ethanol 
treatment, the dried SF powder was mixed with potassium bromide (KBr) and analysed in the 
spectral region of 4000–400 cm-1 with a resolution of 4 cm-1  [26]. 
 
2.1.3. Fabrication of AM/ESF bi-layered membrane 
10% Silk fibroin (SF) solution in formic acid (FA) was prepared as described in our previously 
published study  [21]. For electrospinning, AM membrane (20 Í 3 cm) was fixed to drum 
covered with an aluminium foil. The SF/formic acid solution in a 3-mL syringe was electrospun 
on the dried AM. The electrospinning was performed under the following conditions: A voltage 
of 18 kV/cm, 15 cm distance between the syringe and the collector and 0.3 mL/H constant flow 
rate. In this study, the SF solution was electrospun for 20 minutes (this confirmed the attachment 
of ESF to AM) and 3 h (this finalized AM/ESF bi-layer membrane). AM/ESF was treated with 
70% ethanol for 1 hour and subsequently dried under vacuum. Ethanol treatment was also done 
on AM alone following same procedure. The synthesized bi-layer membrane was kept in 4 C 
until further use. The schematic of bi-layer skin scaffold preparation is illustrated in Figure 1. 
Please insert Figure 1 here 
  






































































2.2. Biological and cellular characterization  
2.2.1. Surface characterization using SEM 
After 20 min and 3 hours of electrospinning the AM and AM/ESF with gold, their morphologies 
were observed under scanning electron microscope (SEM, Philips XL30, Netherlands) at an 
acceleration voltage of 15 kV. The average diameter of the spun nano-fibers (n=10) before and 
after ethanol treatment were determined by SEM software and analysed. 
 
2.2.2 Biomechanical behaviour 
A universal tensile strength testing machine at a crosshead speed of 10 mm·min-1 with a 
specified sample size (length = 20 mm and width = 10 mm) was used to evaluate the 
biomechanical behaviour of the AM and AM/ESF (n=5). Maximum load value (N), suture 
retention strength (mN) (5–0 nylon suture) and strain deflection at break (mm) of the AM/ESF 
were determined by a protocol previously described and compared to those of AM alone [11]. 




The degradation properties of the AM/ESF were determined by enzymatic reaction, namely 0.1 
wt % solution of lysozyme in DMEM culture medium with addition of PBS solutions in vitro, as 
described previously with few modifications [11]. Briefly, the samples were weighed (m0) and 
embedded into 10 ml of degradation solution (PBS or enzyme). All the samples were incubated 
at 37°C for 14 days. 3 samples were removed after each predetermined incubation time, washed 






































































with distilled water and dried at room temperature for 72 hours. The samples were weighed (md) 
and percentage of weight loss was determined by the following formula;  
Weight loss (%) = !!! !!!!  ×100    
2.2.4. Adipose tissue-derived mesenchymal stem cells responses to AM/ESF   
2.2.4.1. The adipose tissue-derived mesenchymal stem cells isolation and expansion 
The AT-MSCs were isolated from inguinal fat pads of BALB/c mice according to procedures 
approved by the Ethics Committee of the Medical Sciences. The isolation protocol is described 
in detail elsewhere [8, 27]. Briefly, 10g of the adipose tissue was collected and mixed with 0.2% 
collagenase II (Sigma, St. Louis, MO, USA) for 30 min at 37 °C under sterile conditions. The 
samples were centrifuged at 2500 rpm for 10 min. The supernatant was removed and the pellet 
was resuspended in DMEM (Dulbecco's Modified Eagle Medium) supplemented with 10%FBS 
1% pen/strep, nystatin and amphotericin B, 2 mM Glutamax, 1 mM L-glutamine and 1% non-
essential amino acids (all from Gibco, Carlsbad, CA, USA). The cells were harvested in two 75-
cm2 flasks. The number of viable cells was assessed based on 0.4% trypan blue exclusion 
(Sigma–Aldrich, USA) method.  
 
2.2.4.2. Characterization of adipose tissue-derived mesenchymal stem cells (AT-MSCs)  
The AT-MSCs were characterized by flow cytometry. The cells were examined for the 
expression of CD34, CD44, CD45, CD73, CD90 and CD105. The AT-MSCs with density of 3 
Í 105 /100 µl were incubated with antibodies in the dark chamber for 30 min at 37 °C. The cells 
were then washed and analysed by flow cytometry as described previously [28]. The AT-MSCs 
were further characterized for their differentiation capacity towards osteogenic and adipogenic 






































































lineages [29, 30]. First the cells were treated with osteogenic differentiation media for three 
weeks and then stained with Alizarin-red (Sigma-Aldrich, USA) to visualize mineralized matrix. 
Next, the cells were treated with adipogenic differentiation media for three weeks and then 
stained with Oil-red (Sigma-Aldrich, USA). The stained cells were viewed and images taken 
under light microscope.  
 
2.2.4.3. Cell adhesion and distribution  
For cell adhesion and distribution studies, the cells were seeded on the membranes (1 Í 1 cm) 
and incubated for 72 hours. The morphology of the cells cultured on the samples was observed 
under SEM [11]. The cells were also stained with 4,6-diamidino-2-phenylindle (DAPI) [31] to 
analyze the cell density along the scaffold. For quantitative analysis, the DAPI stained samples 
were viewed under fluorescent microscope and the cells were counted from 10 different areas 
(100Í magnification). The test was repeated three time and the average of cell count was 
reported as cell density. 
 
2.2.4.4. Long-term cell viability and cytotoxicity  
The AT-MSCs viability and cytotoxicity were evaluated by MTT and LDH specific activity, as 
described previously [8]. Briefly, the cells (1 × 104 cells/well) were cultured on the membranes 
(1 Í 1 cm) for 1, 5, 10 and 15 days in a cell culture incubator (n=3). After each time interval, the 
media were collected and subjected to LDH specific activity assay using a LDH kit (Zist Shimi 
kits, Tehran, Iran) [8]. For cell viability assay, the cells after were treated with 10% MTT 
solution for 1 h and then embedded in dmethyl sulfoxide (DMSO) for 20 min. The optical 





































































density (OD) of the samples was measured using an enzyme-linked immunosorbent assay 
(ELISA) reader at a wavelength of 590 nm. The viability of the AT-MSCs cultured on plastic 
surface of cell culture plate was considered as positive control (100% cell viability). Sterile cell 
culture media with no cells or membrane served as negative control (ODnc). The cell viability 
was determined by the following formula;  
 
2.3. Angiogenesis  
To determine whether the AM/ESF may accelerate post-injury neovascularization, the effects of 
AM/ESF/AT-MSCs cross-talk on secretion of the pro-angiogenic factors such as VEGF and 
bFGF from these cells were evaluated in vitro. For this, the AT-MSCs were seeded on the 
decellularised AM and AM/ESF membrane and incubated at 5% CO2 and 95% air for 7 days. 
The cells cultured on tissue culture plate served as control. After specified time, the cells were 
evaluated for their expression of VEGFa and bFGF in vitro by real-time PCR and 
immunostaining IF? [32].  
 
2.3.1. Real-time PCR 
The total RNA was extracted by RNX-Trizol reagent according to the manufacturer's protocol 
(Cinagen, Tehran, Iran). Transcription of 0.1 µg RNA to cDNA was performed by a High-
Capacity cDNA Archive kit using random hexamer primer according to the supplier’s 
instructions (Applied Biosystems, Foster City, CA, USA). The relative expressions of vascular 
endothelial growth factor (VEGFa) and basic fibroblast growth factor (bFGF) were determined 
by RT-PCR (rotor-gene 6000, Corbett Life Science, Sydney, Australia) using PCR Master Mix 
ODncODsValueAbsorbance −=





































































(TaKaRa, Dalian, China). The expression level of each target gene was normalized against beta-
actin (b-actin) gene. The relative expression was defined based on 2-∆∆Ct. All the primers used in 
this study and the product lengths are listed in Table 1.  
Please insert Table 1 here 
2.3.2. Immunostaining  
For immunostaining, the cells were washed with phosphate buffer saline (PBS) twice and fixed 
with 4% paraformaldehyde (PFA) for 30 min. After permeabilisation of the cells with 0.025% 
Triton X-100 and washing with PBS, the nonspecific binding was blocked by treatment of the 
cells with 10 % goat serum for 30 min. The cells were then treated with primary antibodies anti-
VEGFa and anti-bFGF for 1 h at 37 °C. The FITC-conjugated goat polyclonal antibody to Rabbit 
IgG was used as secondary antibody [33]. All the antibodies were purchased from Abcam, 
Cambridge, MA, USA. The counter stain was performed using DAPI. The positive cells for 
VEGFa and bFGF were counted under fluorescent microscope (Olympus BX51, Japan) and the 
results were reported as average cell number per high-power field (HPF).  
 
2.3.3. Statistical analysis 
The results were analysed by Student’s t -tests One-way ANOVA and Turkey test. The analysis 
was performed using SPSS software (Version 16, SPSS Inc., Chicago, IL, USA). Statistical 
analysis was carried out by applying One-way ANOVA and Turkey test. The P<0.05 was set as 
level of significance.  
 






































































3. Results and Discussion 
3.1. Human amniotic membrane (AM) 
The decellularisation of the AM was described previously [11]. The complete removal of the 
cells and cellular debris was confirmed using dead and live staining, H&E staining and DNA 
assay. It was also confirmed that the decellularisation did not affect the ECM of the AM using 
IHC staining as described in our previous studies [8, 11]. It is generally known that the graft 
rejection limits the use of AM as an allograph. Denudation of the AM may improve cell 
proliferation along with decreased immunogenicity [11, 34]. 
 
3.2. Silk fibroin (SF) characterization  
3.2.1. NMR 
The results obtained from 13C-NMR spectra of the regenerated SF are illustrated in Fig. 2a and 
2b. The distinctive peaks appeared at 16.9 ppm (Cβ of Ala), 43.1 (Cα of Gly) and 50.2 (Cα of 
Ala) of the SF/formic acid solution. The secondary structure of SF molecules in solution can be 
determined by Cβ (Ala) chemical shift. The random coil (Structure III) and β-sheet conformation 
(Structure II) display different peaks at 16.9 and 19.5 ppm, respectively [22]. According to the 
NMR spectra, Cβ (Ala) chemical peak was at 16.9 ppm, indicating random coil structure of SF in 
FA. This is similar to aqueous SF solution.  
Please insert Figure 2 here 
3.2.2. FTIR 
The induced insoluble β-sheet conformational transition of the SF was confirmed by FTIR 
spectroscopy [23, 25]. The infrared spectra of the SF before and after ethanol treatment are 






































































depicted in Figure 2c. The FTIR spectra results of the ethanol-treated SF showed characteristic 
peaks of ß-sheet conformation at 1636 cm-1, 1516 cm-1, 1235 cm-1 and 965 cm-1 with no changes 
in α-helix characteristic peaks (621 cm-1) [23, 26]. 
 
3.3. Human amniotic membrane/electrospun nanofibrous silk fibroin (AM/ESF) 
characterization 
3.3.1. Morphology 
The morphology of the AM/ESF was observed under SEM after 20 min and 3 h electrospinning 
(Fig. 3a). The silk fibroin (10%) nano-fibers were successfully electrospun and arranged in a 
specific orientation as displayed by SEM micrographs. They were homogenous throughout with 
no beaded fibres. In 20 min electrospun samples, the attachment of the SF nano-fibers to the AM 
is clearly observed after ethanol treatment. After alcohol treatment, ESF was tightly coated and 
ensured non separation of the AM. The average diameters of the spun nano-fibers before and 
after ethanol treatment were 93 ± 25 nm and 157 ± 32 nm, respectively (Fig. 3b). The results are 
consistent with previously published report [21].  The tilt view SEM image of the AM/ESF (Fig. 
3a) confirmed the coating of the AM by ESF.  
Please insert Figure 3 here 
3.3.2. Biomechanical behavior 
The effects of the SF electrospinning on the mechanical behaviors of the AM/ESF are 
summarized in Table 2. The AM/ESF showed significantly improved mechanical properties 
including maximum load value, suture retention strength, strain deflection at break and thickness 
when compared with AM samples. Tissue engineering scaffolds must provide sufficient 






































































biomechanical properties for better regeneration of damaged tissues. In our previous study [23], 
we showed that ethanol treatment and subsequently β-sheet structure formation of ESF 
significantly increase its mechanical behaviours. Vasconcelos et al. [35] fabricated a 3D silk 
fibroin/elastin wound dressing with excellent chemical and mechanical properties for biological 
applications. The biomechanical properties of AM/ESF were comparable with other skin 
substitutes using waxes, chondroitin sulfate/hyaluronic acid [14, 36]. For example, Kanokpanont 
and colleagues showed that coating SF fabric with wax increase its biomechanical properties 
with no cytotoxicity effects [14]. Insufficient mechanical property of AM makes it difficult for 
grafting. To address this issue, the researchers are attempting to find a way to enhance 
biomechanical behaviour of AM without affecting its cell adhesion and non-cytotoxicity 
properties. For example, cross-linking of AM with carbodiimide and glutaraldehyde successfully 
enhanced its biomechanical behaviour. Negative effects of such agents on structure, molecular 
stability and cytocompatibility of AM were demonstrated previously [37, 38]. The 
biomechanical testing of this study indicates that the coating the AM with ESF significantly 
increases its mechanical properties and may makes it an excellent 3D skin substitute for skin 
tissue engineering applications. 
Please insert Table 2 here 
3.3.3. In vitro degradation of AM/ESF 
The degradation rate of scaffolds for tissue engineering purpose is very critical and can 
profoundly affect healing effectiveness. Quick degradation of biomaterial causes the scaffold to 
disintegrate too early before healing of the damaged tissue is complete. The in vitro degradation 
rates of the engineered functional materials (AM and AM/ESF) were determined by treatment 
with PBS (Fig. 4a) and lysozyme (Fig. 4b) solution for 14 days. The degradation rate of the 






































































AM/ESF sample showed a significant decrease in weight after 6 and 7 days post-treatment in 
enzymatic and PBS solution, respectively, when compared to the AM sample alone (independent 
sample t-test, p<0.05). The complete degradation of AM occurs during first two weeks [11]. Ma 
et al. [37] reported more than 90% weight loss of AM after 2 weeks in collagenase degradation 
solution. In addition, it was reported that degradation rate of AM varied and depended on its 
preparation, decellularisation and preservation conditions [11, 39]. The results of our previous 
study showed that the denuded AM was degraded faster than the natural AM in both PBS and 
lysozyme solutions [11]. Based on the biodegradation results in the current study, coating the 
AM with ESF slowed the degradation rate of the resulted AM/ESF bi-layer membrane. Skin 
regeneration is an integrated process involving both cells and supporting scaffold. The AM due 
to its biological properties and tissue like characteristics make excellent base membrane for the 
cells to grow and proliferate, while ESF with its viscoelastic nature, ensures the integrity of the 
product and results in slow destruction of the AM membrane. A suitable skin substitute should 
stay on skin wound between 2-3 weeks, depending on wound type and severity [40, 41] . AM 
showed to fully degrade during first week post-grafting [11] which is not optimal to serve as a 
skin substitute. Our results showed improved effect of ESF on enhancing the degradation time of 
AM/ESF to 2 weeks.  
Please insert Figure 4 
3.3.4. The adipose tissue-derived mesenchymal stem cells responses on AM/ESF 
3.3.4.1. Characterization of adipose tissue-derived mesenchymal stem cells (AT-MSCs) 
According to the results obtained from the flow cytometry, 69.6%, 96.8%, 76.5% and 94.4% of 
the cell population were positive for CD44, CD73, CD90 and CD105, respectively (Fig. 5a). 
Only 2.72% and 3.56% of the cells were positive for CD34 and CD45, respectively. The 






































































Alizarin-red and Oil-red staining confirmed that the cells were successfully differentiated into 
both osteogenic and adipogenic lineages (Fig. 5b) [27, 29, 42].  
Please insert Figure 5 here 
3.3.4.2. Cell adhesion and distribution 
Interaction of the cells with surface of biomaterials profoundly affects various cell behavior such 
as adhesion, proliferation and differentiation. These properties strongly depend on the 
physicochemical characteristics and hydrophilicity of the materials [43]. Therefore, cell adhesion 
of tissue engineering scaffolds is of critical importance. The morphologies of the AT-MSCs 
cultured on the AM/ESF before and after ethanol treatment were analyzed by SEM (Fig. 6a). 
The spindle morphology of the AT-MSCs on all the samples was clearly observed at day 3 post-
seeding. The conformation of the AT-MSCs with the surface of the membranes clearly 
represented the effective cell-substrate attachment. The elongated morphology of the cells as 
well as their filopodia-like membrane suggests that all the membranes are suitable for cellular 
adhesion and proliferation. Moreover, DAPI staining was performed to determine the density and 
distribution of the AT-MSCs on the membranes (Fig. 6c). No significant difference was 
observed between the samples (p>0.05) in the cell density. These results are consistent with 
earlier investigations [8, 29, 44] which showed a high attachment of both silk fibroin and 
collagen to L929 cells. Similarly, we previously showed high cell adhesion and increased growth 
of such materials for bone marrow and adipose tissue-derived mesenchymal stem cells [8, 11, 21, 
45]. Presence of proteoglycans, laminin, fibronectin and collagens within AM matrix endow an 
excellent cell attachment to this membrane [10]. As we reported previously, decellularisation 
process does not affect the cell adhesion of mesenchymal stem cells to AM [11]. According to 
this and our previous studies [8, 11, 21, 23], both AM and AM/SF offer desirable cell adhesion. 






































































Such favourable cell adhesion makes it a promising delivery system in tissue engineering 
applications 
 
3.3.4.3. Long-term cell viability and cytotoxicity  
The evaluation of the AM/ESF as potential matrix for the viability of the AT-MSCs was carried 
out based on the survival of the cells in reduced tetrazolium salt solution and formation of the 
crystals within their mitochondria. Determination of the cell viability (Fig. 6b) revealed that 
neither AM nor AM/ESF affected the viability of the AT-MSCs after specific incubation 
intervals. The results were compared to the 100% cell viability (independent sample t-test, 
p>0.05).   
The cytotoxicity of the samples on the AT-MSCs was evaluated by lactate dehydrogenase (LDH) 
specific activity assay. No cytotoxicity of the AM and AM/ESF membranes on the growth of 
AT-MSCs was detected (Fig. 6b). These results are consistent with the earlier relevant 
observations [8, 21, 46-48].  
Please insert Figure 6 here 
3.3. Angiogenic property of AM/ESF 
The AT-MSCs were seeded on the decellularised AM and AM/ESF membranes and incubated in 
a humidified atmosphere of 5% CO2 and 95% air for 7 days. After specific time, the cells were 
evaluated for their expression of VEGFa and bFGF by real-time PCR and immunostaining. The 
results show that the post-injury neovascularization occurs during 7-14 days of healing 
depending on the severity of the wounds. IL-1β, FGF, VEGFa and VEGFR2 are reported to be 
the most important factors involved in angiogenesis. It is reported that bFGF secreted during the 





































































first 3 days of wound repair, whereas VEGF may have a critical role in angiogenesis during days 
4-7 post-injury [49, 50]. In this study, we aimed to show whether the AM/ESF membrane can 
accelerate secretion of these angiogenic cytokines in vitro during first days of healing.  
 
3.3.1. Real-time PCR 
The angiogenic property of AM is debatable. It was reported that AM possesses anti-angiogenic 
properties when was implanted by its epithelial side [51]. Fast neovascularization during the first 
hours of wound healing might remarkably decrease local hypoxia and subsequently accelerate 
healing process [52-54]. Various biomaterials were investigated for acceleration of the 
angiogenesis within damaged area [55, 56]. The angiogenic property of silk fibroin was reported 
by many [36, 57]. AT-MSCs accelerate neovascularization through secretion of a variety of 
angiogenesis factors such as VEGFa, bFGF, IL-1b and others [32, 42]. In this study, we showed 
that the AM/ESF significantly increased the expression levels of VEGFa and bFGF in AT-MSCs 
after 7 days when compared to AM alone and control (p≤0.05) (Fig. 7a). Our findings indicate 
the enhanced the angiogenesis in vitro of the ESF coated over the AM.  
Please insert Figure 7 here 
3.3.2. Immunostaining  
Angiogenesis of the AM/ESF on the AT-MSCs was evaluated by immunostaining of VEGFa and 
bFGF (Fig. 7b). The cells expressing the angiogenesis factors are reported (Fig. 7c). 
Immunostaining revealed increased expressions of VEGFa and bFGF in AT-MSCs (Fig. 7b). 
The results show more than 90% and 70% of the AT-MSCs expressed VEGFa and bFGF, 





































































respectively. These angiogenesis data are also confirmed by our real-time PCR results and 
additional  studies  [36, 57].  
 
4. Conclusion 
The human amniotic membrane (AM) is widely used as a skin substitute in thermal injuries. Yet, 
tt is not fully satisfactory. This stems from the fact that its fast biodegradation rate, low 
mechanical and insufficient angiogenesis characteristics aren’t optimal. . In this study, we 
develop and fully characterize a 3D bi-layer artificial skin made from AM and electrospun 
nanofiberous silk fibroin (ESF). The AM/ESF bi-layer membrane shows improved mechanical 
properties and slower biodegradation rate when compared to AM alone. The ESF allows for AM 
to be maintained in its 3D structure by reducing the bio-absorption rate. Our 3D bi-layer scaffold 
induces the adipose-derived mesenchymal stem cells to up-regulate angiogenic factors such as 
VEGFa and bFGF. These results indicate that the 3D bi-layer AM/ESF scaffold offers an 
attractive alternative in the skin substitute research area.  
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Figure 1. Schematic preparation of the bi-layer artificial skin preparation. dAM: decellularised 
human amniotic membrane; ECs: epithelial cells; AM: human amniotic membrane; MSCs: 
mesenchymal stem cells; ESF: nanofibrous silk fibroin; SF: silk fibroin. 
Figure 2. 13C-NMR spectra of the regenerated silk fibroin (SF) in formic acid at 0-200 ppm (a) 
and 150-200 ppm (b). The distinctive peaks are appeared at 16.9 ppm (Cβ of Ala), 43.1 (Cα of 
Gly) and 50.2 (Cα of Ala) in the SF/FA solution. (c) FTIR spectra of SF before and after 
treatment with 70% ethanol for 1h.  The results confirmed the β-sheet conformational transition 
of the silk fibroin. 
Figure 3. Morphology of the membranes (a) SEM micrographs of the human amniotic 
membrane (AM), AM/electrospun nanofibrous silk fibroin (ESF) (20 min and 3 h 
electrospinning) before and after treatment with ethanol as well as tilt view SEM image of the 
AM/ESF. Black and white arrows indicate ESF and AM, respectively. EUT: Ethanol-untreated, 
ET: Ethanol-treated. (b) Fiber diameter distribution in EUT and ET samples.  
Figure 4. In vitro degradation time (% mass loss) of the samples in PBS and lysozyme solutions 
during 14-days treatment. 
Figure 5. Characterization of AT-MSCs. (a) Flow cytometry analysis of mesenchymal stem cells 
specific markers of CD44, CD73, CD90 and CD105 and hematopoietic lineage specific markers 
of CD34 and CD45. (b) Adipose tissue-derived stem cells (left) cultured in cell culture plate 
before differentiation induction, the Alizarin red stained cells after three weeks induction with 
osteogenic differentiation media (middle) and the Oil red stained cells after three weeks 
induction with adipogenic differentiation media (right).   






































































Figure 6. (a) SEM micrographs of the adipose tissue-derived mesenchymal stem cells (AT-
MSCs) cells cultured on AM/ESF before (EUT) and after (ET) ethanol treatment (b) Cell 
viability and cytotoxicity evaluated by MTT and LDH specific activity assays (c) Distribution of 
the AT-MSCs cultured on the AM, EUT-AM/ESF and ET-AM/ESF membranes after 72 h 
incubation in cell culture incubator. 
Figure 7. In vitro angiogenesis. (a) Relative expression level of VEGFa and bFGF in adipose-
tissue derived mesenchymal stem cells (AT-MSCs) after 7 days culture on cell culture plate 
(control), AM and AM/ESF by real-time PCR. (b) Immunostaining of VEGFa and bFGF in AT-
MSCs, and (c) The percentage of the AT-MSCs expressing VEGFa and bFGF. * indicates 




















































































Table 1. Primers used in RT-PCR analysis. 
 GENE NAME ACCESSION NUMBER SEQUENCE PRODUCT SIZE (BP) 
 Beta actin NM_007393.5 
F: 5΄ CTTCTTGGGTATGGAATCCTG 
R: 5΄ GTGTTGGCATAGAGGTCTTTAC 
96 
 VEGFa NM_001110268.1 
F: 5΄ TCGCTCCTCCACTTCTGAGG 
R: 5΄ GGCCATTACCAGGCCTCTTC 
93 
 bFGF NM_008006.2 
F: 5΄ CCGGTCACGGAAATACTCCA 





Table 2. Mechanical properties of human amniotic membrane (AM) and the bi-layered 



















Maximum load value (N) 1.30±0.17 1.90±0.18 P<0.05* 
Suture retention strength (mN) 512±63 692±31 P<0.05* 
Strain deflection at break (mm) 7.30±0.49 8.50±0.33 P<0.05* 
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